The NAD metabolome--a key determinant of cancer cell biology

Alberto Chiarugi1, Christian Dölle, Roberta Felici

  • 1Department of Preclinical and Clinical Pharmacology, University of Firenze, 50139, Italy.

Nature Reviews. Cancer
|September 29, 2012
PubMed

Insights

Nicotinamide adenine dinucleotide (NAD) is essential for cellular processes altered in cancer. Targeting NAD metabolism offers a promising new therapeutic strategy for cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Nicotinamide adenine dinucleotide (NAD) is a vital coenzyme involved in cellular energy and signal transduction.
  • Cellular processes regulated by NAD, including transcription, DNA repair, and metabolism, are frequently altered in cancer.
  • Cancer cell proliferation relies on continuous NAD resynthesis due to its degradation in signaling pathways.

Purpose of the Study:

  • To highlight the critical role of NAD in fundamental cellular processes.
  • To underscore the importance of NAD metabolism in cancer development and proliferation.
  • To propose targeting NAD metabolism as a novel therapeutic strategy for cancer.

Main Methods:

  • Review of existing literature on NAD metabolism and cancer.
  • Analysis of NAD(+)-dependent signaling pathways.
  • Evaluation of NAD biosynthesis pathways in the context of cancer cell proliferation.

Main Results:

  • NAD is integral to key cellular functions disrupted in cancer.
  • Cancer cells exhibit a high demand for NAD resynthesis to sustain proliferation.
  • Dysregulation of NAD metabolism is a common feature in various cancers.

Conclusions:

  • NAD metabolism is a critical determinant of cancer cell viability.
  • Targeting NAD biosynthesis or degradation pathways presents a viable therapeutic avenue.
  • Modulating NAD levels could offer a new approach to cancer therapy.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

No description available
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

No description available
1.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.4K